Form 4: Jasper Therapeutics Director Buys Shares
Insider Transaction (Form 4)
Patrick J Crutcher, a Director of Jasper Therapeutics, Inc., purchased 888 shares of common stock on July 16, 2026.
Summary
- Grant/award: acquired 15,000 Stock Option (Right to Buy on July 16, 2026; holds 15,000 after (Direct).
- Open-market purchase: acquired 888 Non-Voting Convertible Preferred Stock on July 20, 2026; holds 888 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $0, committing personal capital to the stock.
Insider Transactions
Patrick J Crutcher — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Stock Option (Right to Buy | 15,000 | — | — | 15,000 |
| 2026-07-20 | Open-market purchase | Non-Voting Convertible Preferred Stock | 888 | — | — | 888 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (15,000 shares) |
| 2026-07-20 | Open-market purchase (888 shares) |
Keywords
insider transaction, Form 4, JSPR, Jasper Therapeutics, Inc., bullish, Patrick J Crutcher
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.